Page last updated: 2024-09-03

gefitinib and Carcinoma, Lobular

gefitinib has been researched along with Carcinoma, Lobular in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balslev, E; Bernsdorf, M; Ejlertsen, B; Ingvar, C; Jakobsen, EH; Jörgensen, L; Kimper-Karl, ML; Kroman, N; Saetersdal, A; Tuxen, MK	1
Balslev, E; Bernsdorf, M; Ejlertsen, B; Grabau, D; Harder, E; Jakobsen, EH; Kroman, N; Lykkesfeldt, AE; von der Maase, H	1
Dibbley, SK; Lonardo, F; Piechocki, MP; Yoo, GH	1
Piechocki, MP	1

Trials

2 trial(s) available for gefitinib and Carcinoma, Lobular

Article	Year
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial. Breast cancer research and treatment, 2011, Volume: 126, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Fever; Gefitinib; Humans; Leukopenia; Middle Aged; Neoadjuvant Therapy; Neutropenia; Quinazolines; Receptors, Estrogen; Research Design; Treatment Outcome; Tumor Burden	2011
Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer. Breast cancer research and treatment, 2011, Volume: 128, Issue:1 Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; ErbB Receptors; Estrogen Receptor alpha; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoadjuvant Therapy; Phenotype; Quinazolines; Receptor, ErbB-2	2011

Article

Year

Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial.

Breast cancer research and treatment, 2011, Volume: 126, Issue:2

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Fever; Gefitinib; Humans; Leukopenia; Middle Aged; Neoadjuvant Therapy; Neutropenia; Quinazolines; Receptors, Estrogen; Research Design; Treatment Outcome; Tumor Burden

2011

Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer.

Breast cancer research and treatment, 2011, Volume: 128, Issue:1

Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; ErbB Receptors; Estrogen Receptor alpha; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoadjuvant Therapy; Phenotype; Quinazolines; Receptor, ErbB-2

2011

Other Studies

2 other study(ies) available for gefitinib and Carcinoma, Lobular

Article	Year
Gefitinib prevents cancer progression in mice expressing the activated rat HER2/neu. International journal of cancer, 2008, Apr-15, Volume: 122, Issue:8 Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Acinar Cell; Carcinoma, Lobular; Disease Progression; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Mice; Mice, Inbred BALB C; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Rats; Receptor, ErbB-2; Signal Transduction; Up-Regulation	2008
A stable explant culture of HER2/neu invasive carcinoma supported by alpha-Smooth Muscle Actin expressing stromal cells to evaluate therapeutic agents. BMC cancer, 2008, Apr-24, Volume: 8 Topics: Actins; Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Lobular; Cell Culture Techniques; Cell Line, Tumor; Coculture Techniques; Dose-Response Relationship, Drug; Flow Cytometry; Gefitinib; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Male; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Models, Biological; Muscle, Smooth; Quinazolines; Stromal Cells	2008

Article

Year

Gefitinib prevents cancer progression in mice expressing the activated rat HER2/neu.

International journal of cancer, 2008, Apr-15, Volume: 122, Issue:8

Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Acinar Cell; Carcinoma, Lobular; Disease Progression; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Mice; Mice, Inbred BALB C; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Rats; Receptor, ErbB-2; Signal Transduction; Up-Regulation

2008

A stable explant culture of HER2/neu invasive carcinoma supported by alpha-Smooth Muscle Actin expressing stromal cells to evaluate therapeutic agents.

BMC cancer, 2008, Apr-24, Volume: 8

Topics: Actins; Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Lobular; Cell Culture Techniques; Cell Line, Tumor; Coculture Techniques; Dose-Response Relationship, Drug; Flow Cytometry; Gefitinib; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Male; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Models, Biological; Muscle, Smooth; Quinazolines; Stromal Cells

2008